Abstract
Transmissible spongiform encephalopathies (TSEs) in humans and animals are attributed to protein-only infectious agents, called prions. Prions have been proposed to arise from the conformational conversion of the cellular protein PrPC into a misfolded form (e.g., PrPSc for scrapie), which precipitates into aggregates and fibrils. It has been proposed that the conversion process is triggered by the interaction of the infectious form (PrPSc) with the cellular form (PrPC) or might result from a mutation in the gene for PrPC. However, until recently, all efforts to reproduce this process in vitro had failed, suggesting that host factors are necessary for prion replication. In this review we discuss recent findings such as the cellular factors that might be involved in the conformational conversion of prion proteins and the potential mechanisms by which they could operate.
Similar content being viewed by others
References
Adjou K. T., Simoneau S., Sales N., Lamoury F., Dormont D., Papy-Garcia D., et al. (2003) A novel generation of heparan sulfate mimetics for the treatment of prion diseases. J. Gen. Virol. 84, 2595–2603.
Adler V., Zeiler B., Kryukov V., Kascsak R., Rubenstein R., and Grossman A. (2003) Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro. J. Mol. Biol. 332, 47–57.
Aguzzi A. Heppner F. L., Heikenwalder M., Prinz M., Mertz K., Seeger H., and Glatzel M. (2003) Immune system and peripheral nerves in propagation of prions to CNS. Br. Med. Bull. 66, 141–159.
Alper T., Cramp W. A., Haig D. A., and Clarke M. C. (1967) Does the agent of scrapie replicate without nucleic acid? Nature 214, 764–766.
Arnold J. E., Tipler C., Laszlo L., Hope J., Landon M., and Mayer R. J. (1995) The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain. J. Pathol. 176, 403–411.
Baker C. A. and Manuelidis L. (2003) Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. U. S. A. 100, 675–679.
Baker C. A., Lu Z. Y., Zaitsev I., and Manuelidis L. (1999) Microglial activation varies in different models of Creutzfeldt-Jakob disease. J. Virol. 73, 5089–5097.
Baskakov I. V., Aagaard C., Mehlhorn I., Wille H., Groth D., Baldwin M. A., et al. (2000) Self-assembly of recombinant prion protein of 106 residues. Biochemistry 39, 2792–2804.
Baskakov I. V., Legname G., Prusiner S. B., and Cohen F. E. (2001) Folding of prion protein to its native alphahelical conformation is under kinetic control. J. Biol. Chem. 276, 19,687–19,690.
Basler K., Oesch B., Scott M., Westaway D., Walchli M., Groth D. F., et al. (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46, 417–428.
Bessen R. A. and Marsh R. F. (1992) Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J. Virol. 66, 2096–2101.
Bian L., Yang J. D., Guo T. W., Sun Y., Duan S. W., et al. (2004) Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese. Neurology 63, 241–245.
Blatch G. L., Lassle M., Zetter B. R., and Kundra V. (1997) Isolation of a mouse cDNA encoding mSTI1, a stress-inducible protein containing the TPR motif. Gene 194, 277–282.
Bogdanov M. and Dowhan W. (1999) Lipid-assisted protein folding. J. Biol. Chem. 274, 36,827–36,830.
Bolton D. C., McKinley M. P., and Prusiner S. B. (1982) Identification of a protein that purifies with the scrapie prion. Science 218, 1309–1311.
Booth S., Bowman C., Baumgartner R., Dolenko B., Sorensen G., Robertson C., et al. (2004a) Molecular classification of scrapie strains in mice using gene expression profiling. Biochem. Biophys. Res. Commun. 325, 1339–1345.
Booth S., Bowman C., Baumgartner R., Sorensen G., Robertson C., Coulthart M., et al. (2004b) Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection. J. Gen. Virol. 85, 3459–3471.
Borchelt D. R., Taraboulos A., and Prusiner S. B. (1992) Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 267, 16,188–16,199.
Bosque P. J. and Prusiner S. B. (2000) Cultured cell sublines highly susceptible to prion infection. J. Virol. 74, 4377–4386.
Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., et al. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339–343.
Bruce M. E. (1993) Scrapie strain variation and mutation. Br. Med. Bull. 49, 822–838.
Bruce M. E. (2003) TSE strain variation. Br. Med. Bull. 66, 99–108.
Bruce M., Chree A., McConnell I., Foster J., Pearson G., and Fraser H. (1994) Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 343, 405–411.
Bruce M. E., Will R. G., Ironside J. W., McConnell I., Drummond D., Suttie A., et al. (1997) Transmissions to mice indicate that ‘new variant’ CJD, is caused by the BSE agent. Nature 389, 498–501.
Bueler H., Aguzzi A., Sailer A., Greiner R. A., Autenried P., Aguet M., and Weissmann C. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339–1347.
Campana V., Sarnataro D., and Zurzolo C. (2005) The highways and byways of prion protein trafficking. Trends Cell. Biol. 15, 102–111.
Campana V., Sarnataro D., Fasano C., Casanova P., Paladino S., and Zurzolo C. (2006) Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum. J. Cell Sci. 119, 433–442.
Castilla J., Gutierrez-Adan A., Brun A., Pintado B., Parra B., Ramirez M. A., et al. (2004) Different behavior toward bovine spongiform encephalopathy infection of bovine prionprotein transgenic mice with one extra repeat octapeptide insert mutation. J. Neurosci. 24, 2156–2164.
Castilla J., Saa P., Hetz C., and Soto C. (2005) In vitro generation of infectious scrapie prions. Cell 121, 195–206.
Chesebro B. (1998) BSE and prions: uncertainties about the agent. Science 279, 42,43.
Chesebro B. (2003) Introduction to the transmissible spongiform encephalopathies or prion diseases. Br. Med. Bull. 66, 1–20.
Chiarini L. B., Freitas A. R., Zanata S. M., Brentani R. R., Martins V. R., and Linden R. (2002) Cellular prion protein transduces neuroprotective signals. EMBO J. 21, 3317–3326.
Chiesa R., Piccardo P., Ghetti B., and Harris D. A. (1998) Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21, 1339–1351.
Cohen F. E. and Prusiner S. B. (1998) Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67, 793–819.
Collinge J. (2001) Prion disease of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24, 519–550.
Collinge J., Sidle K. C., Meads J., Ironside J., and Hill A. F. (1996) Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383, 685–690.
Come J. H., Fraser P. E., and Lansbury P. T., Jr. (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl. Acad. Sci. U. S. A. 90, 5959–5963.
Cordeiro Y., Machado F., Juliano L., Juliano M. A., Brentani R. R., Foguel D., and Silva J. L. (2001) DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation. J. Biol. Chem. 276, 49,400–49,409.
Dandoy-Dron F., Guillo F., Benboudjema L., Deslys J. P., Lasmezas C., Dormont D., et al. (1998) Gene expression in scrapie. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts. J. Biol. Chem. 273, 7691–7697.
Davis E. C., Broekelmann T. J., Ozawa Y., and Mecham R. P. (1998) Identification of tropoelastin as a ligand for the 65-kD FK506-binding protein, FKBP65, in the secretory pathway. J. Cell Biol. 140, 295–303.
DeArmond S. J., Sanchez H., Yehiely F., Qiu Y., Ninchak-Casey A., Daggett V., et al. (1997) Selective neuronal targeting in prion disease. Neuron 19, 1337–1348.
Deleault N. R., Lucassen R. W., and Supattapone S. (2003) RNA molecules stimulate prion protein conversion. Nature 425, 717–720.
Doh-Ura K., Iwaki T., and Caughey B. (2000) Lysosomotropic agents and cystenic protease inhibitors inhibit scrapie-associated prion protein accumulation. J. Virol. 74, 4894–4897.
Doh-Ura K., Perryman S., Race R., and Chesebro B. (1995) Identification of differentially expressed genes in scrapie-infected mouse neuroblastoma cells. Microb. Pathog. 18, 1–9.
Edenhofer F., Rieger R., Famulok M., Wendler W., Weiss S., and Winnacker E. L. (1996) Prion protein PrPc interacts with molecular chaperones of the Hsp60 family. J. Virol. 70, 4724–4728.
Ehehalt R., Keller P., Haass C., Thiele C., and Simons K. (2003) Amyloidogenic processing of the Alzheimer beta amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160, 113–123.
Ellis V., Daniels M., Misra R., and Brown D. R. (2002) Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner. Biochemistry 41, 6891–6896.
Ely S., Bonatesta R., Ancsin J. B., Kindy M., and Kisilevsky R. (2001) The in-vitro influence of serum amyloid A isoforms on enzymes that regulate the balance between esterified and un-esterified cholesterol. Amyloid 8, 169–181.
Enari M., Flechsig E., and Weissmann C. (2001) Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. U. S. A. 98, 9295–9299.
Fischer M. B., Roeckl C., Parizek P., Schwarz H. P., and Aguzzi A. (2000) Binding of disease-associated prion protein to plasminogen. Nature 408, 479–483.
Gabizon R., McKinley M. P., Groth D., and Prusiner S. B. (1988) Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl. Acad. Sci. U. S. A. 85, 6617–6621.
Gajdusek D. C. and Gibbs C. J. Jr. (1971) Transmission of two subacute spongiform encephalopathies of man (Kuru and Creutzfeldt-Jakob (disease) to new world monkeys. Nature 230, 588–591.
Gajdusek D. C., Gibbs C. J., and Alpers M. (1966) Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 209, 794–796.
Gambetti P., Kong Q., Zou W., Parchi P., and Chen S. G. (2003) Sporadic and familial CJD: classification and characterisation. Br. Med. Bull. 66, 213–239.
Gauczynski S., Hundt C., Leucht C., and Weiss S. (2001a) Interaction of prion proteins with cell surface receptors, molecular chaperones, and other molecules. Adv. Protein Chem. 57, 229–272.
Gauczynski S., Peyrin J. M., Haik S., Leucht C., Hundt C., Rieger R., et al. (2001b) The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20, 5863–5875.
Graner E., Mercadante A. F., Zanata S. M., Forlenza O. V., Cabral A. L., Veiga S. S., et al. (2000a) Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res. Mol. Brain Res. 76, 85–92.
Graner E., Mercadante A. F., Zanata S. M., Martins V. R., Jay D. G., and Brentani R. R. (2000b) Laminin-induced PC-12 cell differentiation is inhibited following laser inactivation of cellular prion protein. FEBS Lett. 482, 257–260.
Greenwood A. D., Horsch M., Stengel A., Vorberg I., Lutzny G., Maas E., et al. (2005) Cell line dependent RNA expression profiles of prion-infected mouse neuronal cells. J. Mol. Biol. 349, 487–500.
Griffith J. S. (1967) Self-replication and scrapie. Nature 215, 1043–1044.
Harper J. D. and Lansbury P. T. Jr. (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66, 385–407.
Harris D. A. (2003) Trafficking, turnover and membrane topology of PrP. Br. Med. Bull. 66, 71–85.
Heppner F. L., Christ A. D., Klein M. A., Prinz M., Fried M., Kraehenbuhl J. P., and Aguzzi A. (2001) Transepithelial prion transport by M cells. Nat. Med. 7, 976–977.
Hill A. F. and Collinge J. (2001) Strain variations and species barriers. Contrib. Microbiol. 7, 48–57.
Hill A. F., Desbruslais M., Joiner S., Sidle K. C., Gowland I., Collinge J., et al. (1997) The same prion strain causes vCJD and BSE. Nature 389, 448–450.
Hope J. (1994) The nature of the scrapie agent: the evolution of the virino. Ann. N. Y. Acad. Sci. 724, 282–289.
Horiuchi M. and Caughey B. (1999) Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J. 18, 3193–3203.
Horiuchi M., Baron G. S., Xiong L. W., and Caughey B. (2001) Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain. J. Biol. Chem. 276, 15,489–15,497.
Hornemann S. and Glockshuber R. (1998) A scrapie-like unfolding intermediate of the prion protein domain PrP(121–231) induced by acidic pH. Proc. Natl. Acad. Sci. U. S. A. 95, 6010–6014.
Hundt C., Peyrin J. M., Haik S., Gauczynski S., Leucht C., Rieger R., et al. (2001) Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J. 20, 5876–5886.
Hunter N., Goldmann W., Benson G., Foster J. D., and Hope J. (1993) Swaledale sheep affected by natural scrapie differ significantly in PrP genotype frequencies from healthy sheep and those selected for reduced incidence of scrapie. J. Gen. Virol. 74, 1025–1031.
Ironside J. W. (2003) The spectrum of safety: variant Creutzfeldt-Jakob disease in the United Kingdom. Semin. Hematol. 40, 16–22.
Jackson G. S., Hill A. F., Joseph C., Hosszu L., Power A., Waltho J. P., et al. (1999a) Multiple folding pathways for heterologously expressed human prion protein. Biochim. Biophys. Acta 1431, 1–13.
Jackson G. S., Hosszu L. L., Power A., Hill A. F., Kenney J., Saibil H., et al. (1999b) Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283, 1935–1937.
Jansen K., Schafer O., Birkmann E., Post K., Serban H., Prusiner S. B., and Riesner D. (2001) Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form. Biol. Chem. 382, 683–691.
Jarrett J. T. and Lansbury P. T. Jr. (1993) Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055–1058.
Jin T., Gu Y., Zanusso G., Sy M., Kumar A., Cohen M., Gambetti P., and Singh N. (2000) The chaperone protein BiPbinds to a mutant prion protein and mediates its degradation by the proteasome. J. Biol. Chem. 275, 38,699–38,704.
Kazlauskaite J. and Pinheiro T. J. (2005) Aggregation and fibrillization of prions in lipid membranes. Biochem. Soc. Symp. 72, 211–222.
Kazlauskaite J., Sanghera N., Sylvester I., Venien-Bryan C., and Pinheiro T. J. (2003) Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry 42, 3295–3304.
Kempster S., Collins M. E., Aronow B. J., Simmons M., Green R. B., and Edington N. (2004) Clusterin shortens the incubation and alters the histopathology of bovine spongiform encephalopathy in mice. Neuroreport 15, 1735–1738.
Kimberlin R. H., Cole S., and Walker C. A. (1987) Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J. Gen. Virol. 68, 1875–1881.
Kocisko D. A., Come J. H., Priola S. A., Chesebro B., Raymond G. J., Lansbury P. T., and Caughey B. (1994) Cell-free formation of protease-resistant prion protein. Nature 370, 471–474.
Kopacek J., Sagaguchi S., Shigematsu K., et al. (2000) Upregulation of the genes encoding lysosomal hydrolases, a peferin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease. J. Virol. 74, 411–417.
Kurschner C. and Morgan J. I. (1995) The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res. Mol. Brain Res. 30, 165–168.
Lasmezas C. I., Comoy E., Hawkins S., Herzog C., Mouthon F., Konold T., et al. (2005) Risk of oral infection with bovine spongiform encephalopathy agent in primates. Lancet 365, 781–783.
Lasmezas C. I., Deslys J. P., Demaimay R., Adjou K. T., Lamoury F., Dormont D., et al. (1996) BSE transmission to macaques. Nature 381, 743–744.
Lassle M., Blatch G. L., Kundra V., Takatori T., and Zetter B. R. (1997) Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases. J. Biol. Chem. 272, 1876–1884.
Lee S. and Eisenberg D. (2003) Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process. Nat. Struct. Biol. 10, 725–730.
Lee K. S., Linden R., Prado M. A., Brentani R. R., and Martins V. R. (2003) Towards cellular receptors for prions. Rev. Med. Virol. 13, 399–408.
Legname G., Baskakov I. V., Nguyen H. O., Riesner D., Cohen F. E., DeArmond S. J., and Prusiner S. B. (2004) Synthetic mammalian prions. Science 305, 673–676.
Lehmann S. and Harris D. A. (1996) Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc. Natl. Acad. Sci. U. S. A. 93, 5610–5614.
Maissen M., Roeckl C., Clatzel M., Goldmann W., and Aguzzi A. (2001) Plasminogen binds to disease-associated prion protein of multiple species. Lancet 357, 2026–2028.
May B. C., Govaerts C., Prusiner S. B., and Cohen F. E. (2004) Prons: so many fibers, so little infectivity. Trends Biochem. Sci. 29, 162–165.
Mestel R. (1996) Putting prions to the test. Science 273, 184–189.
Miller M. W., Williams E. S., Hobbs N. T., and Wolfe L. L. (2004) Environmental source of prion transmission in mule deer. Emerg. Infect. Dis. 10, 1003–1006.
Montrasio F., Cozzio A., Flechsig E., Rossi D., Klein M. A., Rulicke T., et al. (2001) Blymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice. Proc. Natl. Acad. Sci. U. S. A. 98, 4034–4037.
Morillas M., Swietnicki W., Gambetti P., and Surewicz W. K. (1999) Membrane environment alters the conformational structure of the recombinant human prion protein. J. Biol. Chem. 274, 36,859–36,865.
Morillas M., Vanik D. L., and Surewicz W. K. (2001) On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein. Biochemistry 40, 6982–6987.
Myerowitz R., Lawson D., Mizukami H., Mi Y., Tifft C. J., and Proia R. L. (2002) Molecular pathophysiology in Tay-Sachs and Sandh off diseases as revealed by gene expression profiling. Hum. Mol. Genet. 11, 1343–1350.
Nakanishi H. (2003) Neuronal and microglial cathepsins in aging andage-related diseases. Ageing Res. Rev. 2, 367–381.
Nandi P. K., Leclerc E., Nicole J. C., and Takahashi M. (2002) DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid. J. Mol. Biol. 322, 153–161.
Nishida N., Harris D. A., Vilette D., Laude H., Frobert Y., Grassi J., et al. (2000) Successful transmission of three mouse-adapted scrapie strains to murine neuroblas-tome cell lines overexpressing wild-type mouse prion protein. J. Virol. 74, 320–325.
Oesch B., Teplow D. B., Stahl N., Serban D., Hood L. E., and Prusiner S. B. (1990) Identification of cellular proteins binding to the scrapie prion protein. Biochemistry 29, 5848–5855.
Orgel L. E. (1996) Prion replication and secondary nucleation. Chem. Biol. 3, 413–414.
Pan K. M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., et al. (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U. S. A. 90, 10,962–10,966.
Pan T., Wong B. S., Liu T., Li R., Petersen R. B., and Sy M. S. (2002) Cell-surface prion protein interacts with glycosaminoglycans. Biochem. J. 368, 81–90.
Peretz D., Williamson R. A., Kaneko K., Vergara J., Leclerc E., Schmitt-Ulms G., et al. (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739–743.
Perrier V., Kaneko K., Safar J., Vergara J., Tremblay P., DeArmond S. J., et al. (2002) Dominant-negative inhibition of prion replication in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 99, 13,079–13,084.
Petit-Turcotte C., Stohl S. M., Beffert U., Cohn J. S., Aumont N., Tremblay M., et al. (2001) Apolipoprotein C-Iexpression in the brain in Alzheimer's disease. Neurobiol. Dis. 8, 953–963.
Post K., Pitschke M., Schafer O., Wille H., Appel T. R., Kirsch D., et al. (1998) Rapid, acquisition of beta-sheet structure in the prion protein prior to multimer formation. Biol. Chem. 379, 1307–1317
Priola S. A. and Caughey B. (1994) Inhibition of scrapie-associated PrP accumulation. Probing the role of glyco-saminoglycans in amyloidogenesis. Mol. Neurobiol. 8, 113–120.
Priola S. A. and Chesebro B. (1995) A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J. Virol. 69, 7754–7758.
Prusiner S. B. (1991) Molecular biology of prion diseases. Science 252, 1515–1522
Prusiner S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136–144.
Prusiner S. B. (1998) Prions. Proc. Natl. Acad. Sci. U. S. A. 95, 13,363–13,383.
Prusiner S. B., Scott M., Foster D., Pan K. M., Groth D., Mirenda C., et al. (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673–686.
Race R. E., Fadness L. H., and Chesebro B. (1987) Characterization of scrapie infection in mouse neuroblastoma cells. J. Gen. Virol. 68, 1391–1399.
Rieger R., Edenhofer F., Lasmezas C. I., and Weiss S. (1997) The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3, 1383–1388.
Riemer C., Neidholds S., Burwinkel M., Schwarz A., Schultz J., Kratzschmar J., et al. (2004) Gene expression profiling of scrapie-infected brain tissue. Biochem. Biophys. Res. Commun. 323, 556–564.
Riesner D. (2003) Biochemistry and structure of PrP(C) and PrP(Sc). Br. Med. Bull. 66, 21–33.
Riesner D., Kellings K., Post K., Wille H., Serban H., Groth D., et al. (1996) Disruption of prion rods gene-rates 10-nm spherical particles having high alphahelical content and lacking scrapie infectivity. J. Virol. 10, 1714–1722.
Rubenstein R., Carp R. I., and Callahan S. M. (1984) In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J. Gen. Virol. 65, 2191–2198.
Saborio G. P., Permanne B., and Soto C. (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810–813.
Safar J. G., and Kellings K., Serban A., Groth D., Cleaver J. E., Prusiner S. B., and Riesner D. (2005) Search for a prion-specific nucleic acid. J. Virol. 79, 10,796–10,806.
Sanders C. R. and Nagy J. K. (2000) Misfolding of membrane proteins in health and disease: the lady or the tiger? Curr. Opin. Struct. Biol. 10, 438–442.
Sanghera N. and Pinheiro T. J. (2002) Binding of prion protein to lipid membranes and implications for prion conversion. J. Mol. Biol. 315, 1241–1256.
Sarnataro D., Campana V., Paladino S., Stornaiuolo M., Nitsch L., and Zurzolo C. (2004) PrPC Association with lipid rafts in the early secretory pathway stabilizes its cellular conformation. Mol. Biol. Cell 15, 4031–4042.
Schatzl H. M., Laszlo L., Holtzman D. M., Tatzelt J., De-Armond S. J., Weiner R. I., et al. (1997) Anypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J. Virol. 71, 8821–8831.
Schmitt-Ulms G., Legname G., Baldwin M. A., Ball H. L., Bradon N., Bosque P. J., et al. (2001) Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J. Mol. Biol. 314, 1209–1225.
Schonberger O., Horonchik L., Gabizon R., Papy-Garcia D., Barritault D., and Taraboulos A. (2003) Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis. Biochem. Biophys. Res. Commun. 312, 473–479.
Shibuya S., Higuchi J., Shin R. W., Tateishi J., and Kitamoto T. (1998) Protective prion protein polymorphisms a gainst sporadic Creutzfeldt-Jakob disease. Lancet 351, 419.
Shyng S. L., Heuser J. E., and Harris D. A. (1994) Aglyco-lipid-anchored prion protein is endocytosed via clathrin-coated pits. J. Cell Biol. 125, 1239–1250.
Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C. G., and Simons K. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippo-campal neurons. Proc. Natl. Acad. Sci. U. S. A. 95, 6460–6464.
Soto C., Saborio G. P., and Anderes L. (2002) Cyclic ampli-fication of protein misfolding: application toprion-related disorders and beyond. Trends Neurosci. 25, 390–394.
Staniforth R. A., Giannini S., Higgins L. D., Conroy M. J., Hounslow A. M., Jerala R., et al. (2001) Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J. 20, 4774–4781.
Stockel J. and Hartl F. U. (2001) Chaperonin-mediated de novo generation of prion protein aggregates. J. Mol. Biol. 313, 861–872.
Stuermer C. A., Langhorst M. F., Wiechers M. F., Legler D. F., Von Hanwehr S. H., Guse A. H., and Plattner H. (2004) PrPc capping in T cells promotes its association with the lipid raft proteins reggie-1 and reggie-2 and leads to signal transduction. FASEB J. 18, 1731–1733.
Supattapone S. (2004) Prion protein conversion in vitro. J. Mol. Med. 82, 348–356.
Supattapone S., Nguyen H. O., Cohen F. E., Prusiner S. B., and Scott M. R. (1999) Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl. Acad. Sci. U. S. A. 96, 14,529–14,534.
Taraboulos A., Raeber A. J., Borchelt D. R., Serban D., and Prusiner S. B. (1992) Synthesis and trafficking of prion proteins in cultured cells. Mol. Biol. Cell 3, 851–863.
Taraboulos A., Scott M., Semenov A., Avrahami D., Laszlo L., Prusiner S. B., and Avraham D. (1995) Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell Biol. 129, 121–132.
Telling G. C., Parchi P., DeArmond S. J., Cortelli P., Montagna P., Gabizon R., et al. (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274, 2079–2082.
Telling G. C., Scott M., Hsiao K. K., Foster D., Yang S. L., Torchia M., et al. (1994) Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc. Natl. Acad. Sci. U. S. A. 91, 9936–9940.
Telling G. C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F. E., et al. (1995) Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79–90.
Vilette D., Andreoletti O., Archer F., Madelaine M. F., Vilotte J. L., Lehmann S., and Laude H. (2001) Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc. Natl. Acad. Sci. U. S. A. 98, 4055–4059.
Vorberg I., Raines A., Story B., and Priola S. A. (2004) Susceptibility of common fibroblast cell lines to trans-missible spongiform encephalopathy agents. J. Infect. Dis. 189, 431–439.
Weissmann C. (1991) A ‘unified theory’ of prion propagation. Nature 352, 679–683.
Weissmann C. (2004) The state of the prion. Nat. Rev. Microbiol. 2, 861–871.
Weissmann C. and Flechsig E. (2003) PrP knock-out and PrP transgenic mice in prion research. Br. Med. Bull. 66, 43–60.
Welker E., Raymond L. D., Scheraga H. A., and Caughey B. (2002) Intramolecular versus intermolecular disul-fide bonds in prion proteins. J. Biol. Chem. 277, 33,477–33,481.
Westaway D., DeArmond S. J., Cayetano-Canlas J., Groth D., Foster D., Yang S. L., et al. (1994) Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76, 117–129.
Will R. G., Ironside J. W., Zeidler M., Cousens S. N., Estibeiro K., Alperovitch A., et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921–925.
Wollmer M. A., Streffer J. R., Lutjohann D., Tsolaki M., Iakovidou V., Hegi T., et al. (2003) ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol. Aging 24, 421–426.
Wong C., Xiong L. W., Horiuchi M., Raymond L., Wehrly K., Chesebro B., and Caughey B. (2001) Sullated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J. 20, 377–386.
Xiang W., Windl O., Wunsch G., Dugas M., Kohlmann A., Dierkes N., et al. (2004) Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J. Virol. 78, 11,051–11,060.
Yehiely F., Bamborough P., Da Costa M., Perry B. J., Thinakaran G., Cohen F. E., et al. (1997) Identification of candidate proteins binding to prion protein. Neurobiol. Dis. 3, 339–355.
Zanata S. M., Lopes M. H., Mercadante A. F., Hajj G. N., Chiarini L. B., Nomizo R., et al. (2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21, 3307–3316.
Zhang H., Kaneko K., Nguyen J. T., Livshits T. L., Baldwin M. A., Cohen F. E., et al. (1995) Conformational transitions in peptides containing two putative alpha-helices of the prion protein. J. Mol. Biol. 250, 514–526.
Zhang Y., Spiess E., Groschup M. H., and Burkle A. (2003) Up-regulation of cathepsin B and cathepsin L activities in scrapie-infected mouse Neuro2a cells. J. Gen. Virol. 84, 2279–2283.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fasano, C., Campana, V. & Zurzolo, C. Prions. J Mol Neurosci 29, 195–214 (2006). https://doi.org/10.1385/JMN:29:3:195
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1385/JMN:29:3:195